Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 06, 2026 19:02 ET | Source: Organogenesis Holdings Inc.

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Statistically significant (p<0.0477) DFU wound closure at 12 weeksRCT compared PuraPly®AM plus standard of care to standard of care aloneResults strengthen existing clinical evidence supporting...
April 06, 2026 17:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a...
April 06, 2026 16:05 ET | Source: Outset Medical, Inc.

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in...
April 06, 2026 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the...
April 03, 2026 16:01 ET | Source: Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April...
April 02, 2026 13:55 ET | Source: ApolloMD Inc.

ApolloMD Announces Exclusive Professional Liability Solution with The Doctors Company

ApolloMD partners with The Doctors Company to launch nationwide physician-focused medical liability insurance, boosting protection and support.
April 02, 2026 12:30 ET | Source: GENFIT S.A.

GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société

Faits financiers marquants de 2025 : Trésorerie et équivalents de trésorerie s’élevant à 101.1 millions d’euros au 31 décembre 2025 Chiffre d’affaires s’élevant à 65.4 millions d’euros au 31 décembre...
April 02, 2026 12:30 ET | Source: GENFIT S.A.

GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update

2025 financial highlights: Cash and cash equivalents totaled €101.1 million as of December 31, 2025Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million...
April 01, 2026 09:15 ET | Source: Toronto Regional Real Estate Board

PropTx Partners with MPAC to Deliver Ontario’s Most Comprehensive Residential Appraisal Data Solution

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- PropTx Innovations Inc. (“PropTx”) and the Municipal Property Assessment Corporation (“MPAC”) are partnering to deliver the most comprehensive residential...
April 01, 2026 08:15 ET | Source: Profound Medical Corp.

Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...